Recognition for respected vascular specialist
By Richard Schoonraad | awards, Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Heart, Imaging and Therapy, News & Events, ResearchDirector of the Heart and Vascular Research Institute and Joint Program Head of the Cardiovascular Science and Diabetes Program at the Harry Perkins Medical Research Institute, Professor Shirley Jansen has…
Researchers develop new AI tool to predict heart attack risk
By Richard Schoonraad | Cardiovascular Disease, Cardiovascular Research & Innovation, Cardiovascular Science and Diabetes Program, Heart, News & EventsResearchers from the Harry Perkins Institute of Medical Research, working with medtech industry partners Artrya Limited, have developed a new, fully-automated AI algorithm that is more effective than current methods…
Perkins researchers put paid to plaque in arteries
By Richard Schoonraad | Blood Vessels, Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Cell Signalling, Donation Handles, Funding, Heart, Imaging and Therapy, Media Releases, News & Events, Research, Sarcoma, Targeted Drug Delivery, TreatmentsThe Harry Perkins Institute of Medical Research is celebrating a major milestone in the progression of a world-first drug candidate that has the potential to change the lives of thousands…
Perkins partners with Victor Chang Cardiac Research Institute for better heart outcomes
By Richard Schoonraad | Advanced Clinical and Translational Cardiovascular Imaging, Cardiovascular Disease, Cell Signalling, Community, Donation Handles, Media Releases, News & Events, Research, SarcomaThe Harry Perkins Institute of Medical Research has forged a new partnership with one of Australia’s leaders in heart research. The strategic partnership with the Victor Chang Cardiac Research Institute…
Federal government supports new treatment to clear blocked arteries
By Richard Schoonraad | Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Diabetes, Funding, News & Events, ResearchA Western Australian medical research team developing a new treatment for cardiovascular disease has received $2,147,254 in Federal government funding to develop a first-ever drug to clear blocked arteries. The…
WA researchers excel in nationally competitive grants
By Richard Schoonraad | Breast Cancer, Breast Cancer, Cancer, Cancer, Cancer Epigenetics, Cardiovascular Disease, Cardiovascular Disease, Epigenetics and Genomics Laboratory, Funding, Genome Biology and Genetic Diseases, Media Releases, Mitochondrial disease, Mitochondrial Disease, Mitochondrial Medicine and Biology, News & Events, Research, TranslationEight (8) Federal government grants awarded to the Harry Perkins Institute of Medical Research Two of Australia’s most significant research grants, given only to the nation’s highest performing researchers, have…
AI stethoscope to help detect early signs of heart disease
By Richard Schoonraad | Advanced Clinical and Translational Cardiovascular Imaging, Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Heart, News & Events, TreatmentsNew AI stethoscope could revolutionise medicine and help detect the early signs of heart valve disease A digital stethoscope that will easily be able to detect early signs of heart…
3D Printed heart valves to be commercialised
By Richard Schoonraad | Biomedical engineering, Cardiovascular Disease, Cardiovascular Disease, Heart, Media Releases, News & Events, T3mPLATE Laboratory, Vascular EngineeringCutting-edge biopolymer 3D-printed heart valve technology to be commercialised in Australia to help millions globally suffering from aortic stenosis. CUREator, Australia’s national biotech incubator, funds Western Australian biomedical engineering and…